Cargando…
PTMA, a new identified autoantigen for oral submucous fibrosis, regulates oral submucous fibroblast proliferation and extracellular matrix
Oral submucous fibrosis (OSF) is a chronic, insidious disease. The presence of autoantibodies in sera of OSF patients is the most characteristic and direct evidence of OSF being an autoimmune disease. To identify the specific autoantigens which could contribute to antibody production, the Human Prot...
Autores principales: | Wang, Jie, You, Jialing, Wang, Lekai, Wang, Huimin, Tian, Tian, Wang, Wenjin, Jia, Lina, Jiang, Canhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650380/ https://www.ncbi.nlm.nih.gov/pubmed/29088825 http://dx.doi.org/10.18632/oncotarget.20419 |
Ejemplares similares
-
Oral submucous fibrosis: an update
por: Wollina, Uwe, et al.
Publicado: (2015) -
Oral submucous fibrosis: An update
por: Ray, Jay Gopal, et al.
Publicado: (2017) -
Proliferation and apoptosis markers in oral submucous fibrosis
por: Ranganathan, K, et al.
Publicado: (2011) -
Lipid profile in oral submucous fibrosis
por: Mehrotra, Ravi, et al.
Publicado: (2009) -
Medical management of oral submucous fibrosis
por: Shanbhag, Vagish Kumar Laxman
Publicado: (2015)